TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

MODAGIN

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

MODAGIN

ST13

US500000097828693

Classe

5, 42, 44

Pedido

97828693

Registro

7617828

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

19

Atualização mais recente

24/12/2024

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 42, 44

Data de depósito

08/03/2023

Data de registro

24/12/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

24/12/2024

Última transação

24/12/2024

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Foreign priority

Código do desenho

4

Tipo de titular

99

Localização do titular

Wendelsheim, DE

Examinador

SMITH, BRENDAN

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

MODAG GmbH

Representantes

Ralph G. Fischer Buchanan Ingersoll & Rooney PC

Classificação técnica

Classes Nice

Classe 5Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Medicines for human medical purposes in the nature of pharmaceutical preparations for the use in the treatment of neurodegenerative diseases, Alzheimer's disease, cardiovascular and cerebrovascular diseases, central nervous system, Parkinson's disease; Medicines for veterinary purposes for treatment of neurodegenerative diseases, Alzheimer's disease, cardiovascular and cerebrovascular diseases, central nervous system, Parkinson's disease; Pharmaceuticals and natural remedies, namely, natural remedy preparations for the treatment of neurodegenerative diseases, Alzheimer's disease, cardiovascular and cerebrovascular diseases, central nervous system, Parkinson's disease; Medicines for the treatment of Alzheimer's disease; Medicines for the treatment of neurodegenerative diseases; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Chemical-pharmaceutical preparations for the treatment of neurodegenerative diseases, Alzheimer's disease, cardiovascular and cerebrovascular diseases, central nervous system, Parkinson's disease; Chemical reagents for medical or veterinary purposes; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations and materials for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic reagents for medical purposes; Injectable pharmaceuticals for the treatment of neurodegenerative diseases, Alzheimer's disease, cardiovascular and cerebrovascular diseases, central nervous system, Parkinson's disease; Medicinal preparations and substances for the treatment of neurodegenerative diseases, Alzheimer's disease, cardiovascular and cerebrovascular diseases, central nervous system, Parkinson's disease; Agents against Parkinson's disease, namely, pharmaceutical agents for the treatment of Parkinson's disease; Pharmaceutical medicines in the nature of pharmaceutical preparations for the treatment of neurodegenerative diseases, Alzheimer's disease, cardiovascular and cerebrovascular diseases, central nervous system, Parkinson's disease; Pharmaceutical products for the treatment of neurodegenerative diseases, Alzheimer's disease, cardiovascular and cerebrovascular diseases, central nervous system, Parkinson's disease; Pharmaceutical preparations for human use for the treatment of neurodegenerative diseases, Alzheimer's disease, cardiovascular and cerebrovascular diseases, central nervous system, Parkinson's disease; Pharmaceutical preparations for the treatment of Parkinson's disease; Pharmaceutical preparations for the treatment of Alzheimer's disease; Pharmaceutical preparations for the treatment of neurodegenerative diseases; Pharmaceutical preparations for the treatment of cerebral disease; Pharmaceutical preparations for the treatment of central nervous system diseases

Classe 42

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Consultancy relating to pharmaceutical research and development; Biological research, clinical research and medical research in the field of pharmaceuticals; Medical research laboratory services; Conducting technical tests on pharmaceuticals; Conducting analysis of human serum for medical research; Conducting analysis of human tissues for medical research; Development of pharmaceutical preparations and medicines; Pharmaceutical products development; Research and development of vaccines and medicines; Providing scientific information in the field of medical disorders and their treatment; Research in the field of pharmacogenetics; Research relating to pharmaceuticals; Research and development in the field of pharmacy and biotechnology; Clinical research in the field of pharmaceuticals; Laboratory research services relating to pharmaceuticals; Medical research; Medical and pharmacological research services; Pharmaceutical drug development services; Pharmaceutical research services; Pharmaceutical research and development; Quality testing for pharmaceutical products; Scientific research in the field of pharmacy; Scientific research and development

Classe 44

Medication counseling; Providing information to patients in the field of administering medications; Providing medical information relating to pharmaceutical products; Providing information relating to the treatment of degenerative diseases; Providing information relating to medical services; Medical advisory services relating to degenerative diseases; Medical consultancy and medical information services relating to pharmaceutical products; Medical consultancy and medical information services relating to pharmaceutical products provided via the Internet; Medical consultancy and medical information services relating to medical products; Medical consultancy services relating to medicines; Medical services; Medical services for the treatment of Alzheimer's disease; Pharmaceutical compounding services; Preparation and administration of medicines being medical services

Publicações

Histórico de despachos e eventos da marca no USPTO.

19 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

24/12/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

24/12/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

22/10/2024

PUBO

PUBLISHED FOR OPPOSITION

22/10/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/10/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

13/09/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/08/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/08/2024

ALIE

ASSIGNED TO LIE

10/08/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

25/03/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

25/03/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

25/03/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

23/02/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/12/2023

GNRT

NON-FINAL ACTION E-MAILED

07/12/2023

CNRT

NON-FINAL ACTION WRITTEN

07/12/2023

DOCK

ASSIGNED TO EXAMINER

06/12/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

28/03/2023

NWAP

NEW APPLICATION ENTERED

11/03/2023

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace MODAGIN ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.